About: History of COVID-19 vaccine development     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Thing, within Data Space : dbpedia.org associated with source document(s)
QRcode icon
http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FHistory_of_COVID-19_vaccine_development

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering the urgent international response to prepare for an outbreak and hasten development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations

AttributesValues
rdfs:label
  • تاريخ تطوير لقاحات مرض فيروس كورونا 2019 (ar)
  • Història del desenvolupament de vaccins contra la COVID-19 (ca)
  • Historie výzkumu vakcín proti covidu-19 (cs)
  • History of COVID-19 vaccine development (en)
rdfs:comment
  • ما إن بدأت إجراءات عزل فيروس كورونا في ديسمبر 2019، ونشر تسلسل حمضه النووي في 11 يناير 2020، حتى ظهرت استجابة دولية عاجلة للاستعداد لتفشي المرض والإسراع بتطوير لقاح وقائي. منذ أوائل عام 2020، عُجل تطوير لقاح للمرض من خلال تعاون غير مسبوق بين الحكومات وشركات صناعة الأدوية متعددة الجنسيات. بحلول يونيو 2020، استثمرت عشرات المليارات من الدولارات من قبل الشركات والحكومات والمنظمات الصحية الدولية ومجموعات البحث الجامعية لتطوير عشرات اللقاحات المرشحة والاستعداد لبرامج التطعيم العالمية للتحصين ضد عدوى مرض فيروس كورونا 2019. (ar)
  • Després d'aïllar el SARS-CoV-2 el desembre de 2019, la seva seqüència genètica es va publicar l'11 de gener de 2020, provocant una resposta internacional urgent per preparar-se per a un brot i accelerar el desenvolupament d'una vacuna contra la COVID-19. Des de principis del 2020, el desenvolupament de vacunes es va accelerar mitjançant una col·laboració sense precedents a la indústria farmacèutica multinacional i entre governs. A juny de 2020, corporacions, governs, organitzacions sanitàries internacionals i grups de recerca universitaris van invertir desenes de milers de milions de dòlars per desenvolupar desenes de candidats a la vacuna i preparar-se per a programes globals de vacunació contra la infecció per COVID-19. Segons la Coalició per a les Innovacions en Preparació per Epidèmies (ca)
  • SARS-CoV-2 (koronavirus 2 těžkého akutního respiračního syndromu), virus způsobující covid-19, byl izolován na konci roku 2019. Ke zveřejnění jeho genetické sekvence došlo 11. ledna 2020. Vyvolalo to naléhavou mezinárodní odezvu na urychlení vývoje ochranné vakcíny proti covidu-19. Od roku 2020 byl vývoj vakcín urychlen díky bezprecedentní spolupráci mezi členy nadnárodního farmaceutického průmyslu a mezi vládami. Do června 2020 korporace, vlády, mezinárodní zdravotnické organizace a univerzitní výzkumné skupiny investovaly desítky miliard dolarů do vývoje desítek na vakcínu a do přípravy globálních očkovacích programů proti infekci covidu-19. Podle Koalice pro inovativní epidemickou připravenost se na geografickém rozložení vývoje vakcíny ukazuje, že severoamerické subjekty mají asi 40 % (cs)
  • SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering the urgent international response to prepare for an outbreak and hasten development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Covid_vaccine_clinical_trial,_Padjajaran_University_(cropped).jpg
  • http://commons.wikimedia.org/wiki/Special:FilePath/COVID-19_vaccine_in_NIAID_lab_freezer.jpg
  • http://commons.wikimedia.org/wiki/Special:FilePath/NIAID_scientist_researching_COVID-19_vaccine.jpg
  • http://commons.wikimedia.org/wiki/Special:FilePath/Pfizer-BioNTech_COVID-19_vaccine_(2020)_G.jpg
  • http://commons.wikimedia.org/wiki/Special:FilePath/Scientist_examines_COVID-19_vaccine_agar_plate.jpg
  • http://commons.wikimedia.org/wiki/Special:FilePath/The_vaccine_development_process_typically_takes_10_to_15_years_under_a_traditional_timeline._Multiple_regulatory_pathways,_such_as_Emergency_Use_Authorization,_can_be_used_to_facilitate_bringing_a_vaccine_for_COVID-19_to_(49948301848).jpg
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 54 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software